These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3141344)

  • 1. The penetration of fleroxacin into bronchial mucosa.
    Wise R; Honeybourne D; Andrews JM; Ashby JP
    J Antimicrob Chemother; 1988 Aug; 22(2):203-6. PubMed ID: 3141344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the penetration of ciprofloxacin and amoxycillin into the bronchial mucosa.
    Honeybourne D; Andrews JM; Ashby JP; Lodwick R; Wise R
    Thorax; 1988 Sep; 43(9):715-9. PubMed ID: 3194878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penetration of fleroxacin into maxillary sinus mucosa and palatine tonsil.
    Baba S; Mori Y; Maruo T
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():195-7. PubMed ID: 3144538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penetration of ciprofloxacin and fleroxacin into biliary tract.
    Edmiston CE; Suarez EC; Walker AP; Demeure MP; Frantzides CT; Schulte WJ; Wilson SD
    Antimicrob Agents Chemother; 1996 Mar; 40(3):787-91. PubMed ID: 8851613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The penetration of ciprofloxacin into bronchial mucosa, lung parenchyma, and pleural tissue after intravenous administration.
    Dan M; Torossian K; Weissberg D; Kitzes R
    Eur J Clin Pharmacol; 1993; 44(1):101-2. PubMed ID: 8436147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penetration of ciprofloxacin in bronchial secretions after intravenous administration.
    Berré J; Thys JP; Husson M; Gangji D; Klastersky J
    J Antimicrob Chemother; 1988 Oct; 22(4):499-504. PubMed ID: 3204076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the penetration of two quinolones into intra-abdominal abscess.
    Tudor RG; Youngs DJ; Yoshioka K; Burdon DW; Keighley MR
    Arch Surg; 1988 Dec; 123(12):1487-90. PubMed ID: 3142444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penetration of fleroxacin and ciprofloxacin into skin blister fluid: a comparative study.
    Lubowski TJ; Nightingale C; Sweeney K; Quintiliani R; Zhi J
    Antimicrob Agents Chemother; 1992 Mar; 36(3):651-5. PubMed ID: 1622179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefepime concentrations in bronchial mucosa and serum following a single 2 gram intravenous dose.
    Chadha D; Wise R; Baldwin DR; Andrews JM; Ashby JP; Honeybourne D
    J Antimicrob Chemother; 1990 Jun; 25(6):959-63. PubMed ID: 2196260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative bronchoalveolar concentrations of ciprofloxacin and lomefloxacin following oral administration.
    Baldwin DR; Wise R; Andrews JM; Gill M; Honeybourne D
    Respir Med; 1993 Nov; 87(8):595-601. PubMed ID: 8290743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproducibility of the measurement of ciprofloxacin concentration in bronchial mucosa.
    Winter J; Sweeney G
    J Antimicrob Chemother; 1991 Mar; 27(3):329-33. PubMed ID: 2037538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penetration of fleroxacin into prostatic secretion and prostatic adenoma tissue.
    Kees F; Naber KG; Schumacher H; Grobecker H
    Chemotherapy; 1988; 34(6):437-43. PubMed ID: 2468456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The penetration of fleroxacin into intra-abdominal abscesses.
    Youngs DJ; Tudor RG; Yoshioka K; Keighley MR
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():115-8. PubMed ID: 3144528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and body fluid penetration of fleroxacin in healthy volunteers.
    Sorgel F; Metz R; Naber K; Seelmann R; Muth P
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():155-67. PubMed ID: 3144534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single and multiple dose pharmacokinetics of fleroxacin.
    Weidekamm E; Portmann R; Partos C; Dell D
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():145-54. PubMed ID: 3144533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolism and pharmacokinetics of fleroxacin in healthy subjects.
    Griggs DJ; Wise R; Kirkpatrick B; Ashby JP
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():191-4. PubMed ID: 3144537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bactericidal kinetics of various dosages of fleroxacin simulated in bacterial cultures.
    Bauernfeind A; Eberlein E; Hörl G
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():81-9. PubMed ID: 3144553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetics and tolerance of fleroxacin in healthy male volunteers.
    Nakashima M; Kanamaru M; Uematsu T; Takiguchi A; Mizuno A; Itaya T; Kawahara F; Ooie T; Saito S; Uchida H
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():133-44. PubMed ID: 3144532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and tissue penetration of fleroxacin after single and multiple 400- and 800-mg-dosage regimens.
    Panneton AC; Bergeron MG; LeBel M
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1515-20. PubMed ID: 3142338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentrations of cefpodoxime in serum and bronchial mucosal biopsies.
    Baldwin DR; Wise R; Andrews JM; Honeybourne D
    J Antimicrob Chemother; 1992 Jul; 30(1):67-71. PubMed ID: 1429338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.